{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:09:17Z","timestamp":1791256157775,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jnutbio.2026.110459","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:58:52Z","timestamp":1783781932000},"page":"110459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CYP450 network shifts in MASLD\/MASH: from pathogenesis to nutrition-informed modulation"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-0161","authenticated-orcid":false,"given":"S\u00fcmeyye","family":"Ko\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2069-8434","authenticated-orcid":false,"given":"Sude","family":"Toydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-6801","authenticated-orcid":false,"given":"G\u00f6kay","family":"Vardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-3984","authenticated-orcid":false,"given":"Gamze Nur","family":"\u00d6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-9732","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"Yusufo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2026.110459_bib0001","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0003","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0004","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0005","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0006","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0007","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0009","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0011","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0012","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0013","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0014","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.gendis.2021.12.013","article-title":"New insight of obesity-associated NAFLD: dysregulated \u201ccrosstalk\u201d between multi-organ and the liver?","volume":"10","author":"Di","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome P450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0016","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance","volume":"68","author":"Zelber-Sagi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0017","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0018","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/nu11091987","article-title":"Dietary fructose and the metabolic syndrome","volume":"11","author":"Taskinen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0019","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41467-023-37209-1","article-title":"Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease","volume":"14","author":"Powell","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jox11030007","article-title":"The Central role of cytochrome P450 in xenobiotic metabolism-a brief review on a fascinating enzyme Family","volume":"11","author":"Esteves","year":"2021","journal-title":"J Xenobiot"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0023","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0024","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.apsb.2022.08.005","article-title":"The role of CYP1A1\/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia","volume":"13","author":"Lu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0025","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s00394-020-02421-y","article-title":"The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies","volume":"60","author":"Zarezadeh","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0026","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ph13090222","article-title":"Nonalcoholic fatty liver disease (NAFLD) and hepatic cytochrome P450 (CYP) enzymes","volume":"13","author":"Jamwal","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0027","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/nu17132098","article-title":"Ultra-processed foods and metabolic dysfunction-associated steatotic liver disease (MASLD): what is the evidence so far?","volume":"17","author":"Geladari","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0028","article-title":"Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: a systematic review","volume":"6","author":"Grinshpan","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"Ter Horst","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0030","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjum\u00e4ki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103560","article-title":"Exploring human CYP4 enzymes: physiological roles, function in diseases and focus on inhibitors","volume":"28","author":"Zhou","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277053","article-title":"Human CYP2B6 produces oxylipins from polyunsaturated fatty acids and reduces diet-induced obesity","volume":"17","author":"Heintz","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0034","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.drudis.2020.07.002","article-title":"Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications","volume":"25","author":"Sisignano","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0036","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"Malhi","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114841","article-title":"CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)","volume":"195","author":"Osborne","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0039","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.21427","article-title":"Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells","volume":"44","author":"Nieto","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0040","article-title":"Effect of BI-1 on insulin resistance through regulation of CYP2E1","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12718","article-title":"Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance","volume":"17","author":"Yang","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0042","doi-asserted-by":"crossref","first-page":"E885","DOI":"10.1152\/ajpendo.00284.2024","article-title":"CYP1A1\/1A2 enzymes mediate glucose homeostasis and insulin secretion in mice in a sex-specific manner","volume":"328","author":"Ching","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0043","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12986-023-00762-z","article-title":"METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6","volume":"20","author":"Li","year":"2023","journal-title":"Nutr Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0044","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0046","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/138920009787522151","article-title":"Role of NF-\u03baB in the regulation of cytochrome P450 enzymes","volume":"10","author":"Zordoky","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0047","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fj.02-0195fje","article-title":"Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved","volume":"16","author":"Jover","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0049","doi-asserted-by":"crossref","first-page":"14568","DOI":"10.1073\/pnas.1211611109","article-title":"Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism","volume":"109","author":"Liu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0050","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1152\/ajpendo.00273.2022","article-title":"Decreased adiponectin\/leptin ratio relates to insulin resistance in adults with obesity","volume":"324","author":"Castela","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0051","article-title":"CHIP\u2212\/\u2212-mouse liver: adiponectin-AMPK-FOXO-activation overrides CYP2E1-elicited JNK1-activation, delaying onset of NASH: therapeutic implications","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0052","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.2000.2125","article-title":"Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob\/ob mice","volume":"268","author":"Leclercq","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0053","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2012.11.035","article-title":"Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis","volume":"58","author":"Chatterjee","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0054","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1124\/dmd.110.035568","article-title":"Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism","volume":"38","author":"Gao","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0055","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of Human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0057","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0058","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1021\/acs.molpharmaceut.8b00159","article-title":"Nonalcoholic fatty liver disease and diabetes are associated with decreased CYP3A4 protein expression and activity in Human liver","volume":"15","author":"Jamwal","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0059","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0060","first-page":"423","article-title":"The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P450 during sepsis","volume":"21","author":"Zhou","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0061","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.xphs.2019.11.007","article-title":"Dietary-induced obesity, hepatic cytochrome P450, and lidocaine metabolism: comparative effects of high-fat diets in mice and rats and reversibility of effects with normalization of diet","volume":"109","author":"Al Nebaihi","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0062","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1734-1140(10)70311-X","article-title":"Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids","volume":"62","author":"Arnold","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100932","article-title":"P2-HNF4\u03b1 alters linoleic acid metabolism and mitigates soybean oil-induced obesity: role for oxylipins","volume":"66","author":"Deol","year":"2025","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0064","article-title":"Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota","volume":"14","author":"Liu","year":"2025","journal-title":"Food Sci Hum Wellness"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0065","article-title":"Quercetin-driven akkermansia muciniphila alleviates obesity by modulating bile acid metabolism via an ILA\/m6A\/CYP8B1 signaling","volume":"12","author":"Liu","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0066","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30652","article-title":"Fructose promotes leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and nitrative stress","volume":"73","author":"Cho","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0067","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0007114519001612","article-title":"Hepatic transcriptomics analysis reveals that fructose intervention down-regulated xenobiotics-metabolising enzymes through aryl hydrocarbon receptor signalling suppression in C57BL\/6N mice","volume":"122","author":"Pan","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0068","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbi.2015.06.022","article-title":"Effect of tetrahydrocurcumin on the profiles of drug-metabolizing enzymes induced by a high fat and high fructose diet in mice","volume":"239","author":"Jearapong","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0069","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0071","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/jbmr.3686","article-title":"Obesity decreases hepatic 25-hydroxylase activity causing low serum 25-hydroxyvitamin D","volume":"34","author":"Roizen","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0072","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.livres.2023.07.002","article-title":"Retinoic acid signaling in fatty liver disease","volume":"7","author":"Cassim Bawa","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0073","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.3350\/cmh.2022.0336","article-title":"Screening strategy for non-alcoholic fatty liver disease","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0074","article-title":"Combination of vitamin C and curcumin safeguards against methotrexate-induced acute liver injury in mice by synergistic antioxidant effects","volume":"9","author":"Hasan Khudhair","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0075","first-page":"2277","article-title":"Elucidation of the role of \u03b1-lipoic acid and vitamin C in methotrexate-induced hepatoxicity in mice","volume":"27","author":"Al-Kuraishy","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0076","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1021\/bi301092c","article-title":"Oxidation of methyl and ethyl nitrosamines by cytochromes P450 2E1 and 2B1","volume":"51","author":"Chowdhury","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0077","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.3390\/foods13213502","article-title":"Mycotoxins in food: cancer risks and strategies for control","volume":"13","author":"Mafe","year":"2024","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.jnutbio.2026.110459_bib0078","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-019-2197-6","article-title":"Critical role of caveolin-1 in aflatoxin B1-induced hepatotoxicity via the regulation of oxidation and autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0079","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/app9122467","article-title":"Analysis of the molecular interactions between Cytochromes P450 3A4 and 1A2 and aflatoxins: a docking study","volume":"9","author":"Garc\u00eda-Montoya","year":"2019","journal-title":"Appl Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.988083","article-title":"Unravelling the pharmacokinetics of aflatoxin B1: in vitro determination of Michaelis\u2013Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes","volume":"13","author":"Lootens","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0081","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2024.11.027","article-title":"Short-term exposure to low doses of aflatoxin B1 aggravates nonalcoholic steatohepatitis by TLR4-mediated necroptosis","volume":"226","author":"Zeng","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0082","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/00498250802008615","article-title":"Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes","volume":"38","author":"Price","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0083","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10937404.2013.842523","article-title":"Sucralose, a synthetic organochlorine sweetener: overview of biological issues","volume":"16","author":"Schiffman","year":"2013","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0084","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/ph15111400","article-title":"Aspartames alter pharmacokinetics parameters of Erlotinib and Gefitinib and elevate liver enzymes in Wistar rats","volume":"15","author":"AlRasheed","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/953952","article-title":"Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner","volume":"2009","author":"Mizutani","year":"2009","journal-title":"J Environ Public Health"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0086","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajcnut.2023.10.014","article-title":"Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants","volume":"119","author":"Zhao","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0087","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cofs.2016.01.005","article-title":"Thermal process contaminants: acrylamide, chloropropanols and furan","volume":"7","author":"Mogol","year":"2016","journal-title":"Curr Opin Food Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0088","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/toxsci\/kfi307","article-title":"Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts","volume":"88","author":"Ghanayem","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0089","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1089\/ars.2022.0055","article-title":"Acrylamide-induced hepatotoxicity through oxidative stress: mechanisms and interventions","volume":"38","author":"Zhang","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.acthis.2015.09.004","article-title":"Acrylamide alters glycogen content and enzyme activities in the liver of juvenile rat","volume":"117","author":"Kovac","year":"2015","journal-title":"Acta Histochem"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0091","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0092","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.3390\/molecules27248855","article-title":"Silymarin protects against acute liver injury induced by acetaminophen by downregulating the expression and activity of the CYP2E1 enzyme","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0093","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389200216666150812123554","article-title":"Diallyl sulfide: potential use in novel therapeutic interventions in alcohol, drugs, and disease mediated cellular toxicity by targeting cytochrome P450 2E1","volume":"16","author":"Rao","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0094","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/antiox10081314","article-title":"Curcumin suppresses the lipid accumulation and oxidative stress induced by benzo[a]pyrene toxicity in HepG2 cells","volume":"10","author":"Lee","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep31557","article-title":"Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models","volume":"6","author":"Basheer","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0096","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3390\/ph18111633","article-title":"In vitro and in vivo effects of resveratrol on rat hepatic CYP1A2","volume":"18","author":"Hern\u00e1ndez-Ojeda","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0097","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bcp.15990","article-title":"Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: impact on pharmacokinetics and drug-drug interactions","volume":"90","author":"Armani","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0098","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.893","article-title":"Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice","volume":"9","author":"Togao","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0099","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094967","article-title":"Chronic inflammatory status observed in patients with type 2 diabetes induces modulation of cytochrome P450 expression and activity","volume":"22","author":"Darakjian","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0101","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.775","article-title":"The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs","volume":"9","author":"Trenaman","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0102","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/dmd.115.067900","article-title":"Interindividual variability in Cytochrome P450\u2013mediated drug metabolism","volume":"44","author":"Tracy","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0103","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0104","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1111\/bcp.15349","article-title":"Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity","volume":"88","author":"Kvitne","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.abb.2015.02.010","article-title":"Cytochrome P450 1B1: an unexpected modulator of liver fatty acid homeostasis","volume":"571","author":"Larsen","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0106","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/cts.13394","article-title":"Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity","volume":"15","author":"Kvitne","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jnutbio.2026.110459_bib0107","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/oby.21692","article-title":"Lipidomic profiling of high-fat diet-induced obesity in mice: importance of cytochrome P450-derived fatty acid epoxides","volume":"25","author":"Wang","year":"2017","journal-title":"Obesity"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:52Z","timestamp":1788779872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286326002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":107,"alternative-id":["S0955286326002019"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110459","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP450 network shifts in MASLD\/MASH: from pathogenesis to nutrition-informed modulation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110459"}}